Global Hemostats Market is Estimated to be Worth USD 2.9 Billion by 2021, at a Developing CAGR of 6.2%

10 Mar, 2016, 11:45 ET from MicroMarket Monitor

PUNE, India, March 10, 2016 /PRNewswire/ --

According to the new Market Research Report "Global Hemostats Market, By Type (Thrombin-Based, Oxidized Regenerated Cellulose Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, And Collagen Based Hemostats), - Global Forecast To 2021", the global Hemostats report defines and segments the concerned market in globally with analysis and forecast of revenue. The global Hemostats market is pegged at USD 2.4 billion in 2015 and is estimated to grow to around USD 2.9 billion by 2021, at a developing CAGR of 6.2 % from 2016 to 2021.

Browse through the TOC of Global Hemostats Market for an in-depth analysis of the industry trends and segments, with help of various tables and figures.

Early buyers will receive 10% customization on this report. 

Global Hemostats market growth is attributed to the rise in the surgery procedures and increasing the number of insurance providers of the hemostats products in the market. Despite this, high cost of Hemostats devices hindering the market. In 2015, about 62.8 % of the Global Hemostats market was dominated by Americas. Over the years, these products have been used during surgeries to stop bleeding within a short span of time. These products are biodegradable, absorbable, and cost-effective. They have tenure of maximum 2 years with no adverse effects.

For more Inquiries:

This market is segmented and forecasted on the basis of product type and geography. The type comprises of thrombin-based, oxidized regenerated cellulose based hemostats, combination hemostats, gelatin based hemostats, and collagen based hemostats are discussed. Here, thrombin based hemostats dominates the global hemostats market. The market is further segmented and forecasted on the basis of major geographies such as Americas, Europe, Asia-pacific and Middle East and Africa covering around 49 countries. Americas dominates the global hemostats market followed by European countries.

Key Players of Global Hemostats Market includes:  

Johnson & Johnson Services, Inc. (U.S.). C. R. Bard, Inc. (U.S.), Baxter (U.S.), B Braun Melsungen AG (Germany), Pfizer Inc. (U.S.), Vascular Solutions, Inc. (U.S.), Gelita Medical GmbH (Germany), Equimedical (Netherlands), Integra Lifesciences Holdings Corporation (U.S.), Z-Medica, LLC (U.S.), and Marine Polymer Technologies, Inc. (U.S.) among others and so on.

This report also includes the market share, approach for arriving the market size, new technology developments, product matrix, life cycle analysis, Porter's five forces analysis and price analysis by product.  In this report, market metrics are also included such as drivers, restraints and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players in the market including major companies which provide Hemostats as a product.

Report Subscription: 

MicroMarket Monitor produces exclusive market research reports, based on real-time data to provide better understanding of the dynamic market conditions of the Healthcare industry. The reports offer in-depth and complete analysis of the regional and country level marketplaces. The research reports for Healthcare industry are updated on quarterly basis and are easily available for purchase through annual subscriptions.    

About MicroMarket Monitor: 

MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.

Mr. Priyank Tiwari 
UNIT no 802, Tower No. 7, SEZ
Magarpatta City, Hadapsar
Pune, Maharashtra 411013,
Tel: +1-888-502-0539 

SOURCE MicroMarket Monitor